obudanersen clinical trials

REVEAL: A Phase 3 Study of Obudanersen (ION582) in Angelman Syndrome

This study is testing a new medicine, ION582, for Angelman syndrome. It wants to see if the medicine is safe and helps children and adults with the condition, which affects development and causes seizures.